CRISPR cuts disease course short in blood disorders

2021 
Gene editing for sickle cell disease and β-thalassemia results in potential curative response.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    1
    References
    0
    Citations
    NaN
    KQI
    []